The chemotherapeutic CX-5461 largely targets TOP2B and displays selective activity in significant-risk neuroblastoma guide RNAs inside of a genome-large CRISPR monitor in both a DMSO or CX-5461 treated CHP-134 cells. j Pre-rRNA forty five S expression in CX-5461 dealt with cell strains rel